AN2 Therapeutics (ANTX) Interest & Investment Income (2021 - 2026)
AN2 Therapeutics' Interest & Investment Income was $720,000 in Q2 2026, down 4.5% from $754,000 a year earlier but up 37.7% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Interest & Investment Income (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, AN2 Therapeutics' Interest & Investment Income was $2.54 million through Jun 30, 2026, down 36.4% year-over-year; for FY2025, it came in at $2.93 million, down 46.3% from FY2024.
- Interest & Investment Income shows a four-year compound annual growth rate of 155.4% (FY2021 to FY2025).
- In earlier years, Interest & Investment Income was $5.47 million in FY2024 (+12.5%), $4.86 million in FY2023 (+259.7%), $1.35 million in FY2022 and $69,000 in FY2021.
- Quarterly Interest & Investment Income has moved between $25,000 (Q3 2021) and $1.68 million (Q1 2024) over five years.
- Compared with a year earlier, Interest & Investment Income has declined for six straight quarters, with an average decline of 38.3% over the last six quarters.
- Per Business Quant data, ANTX's Interest & Investment Income in the three quarters before Q2 2026 was $523,000 (Q1 2026), $605,000 (Q4 2025) and $687,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | AN2 Therapeutics | 207.32 Mn | 207.32 Mn | - | 720,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720,000.00 |
| Mar 31, 2026 | 523,000.00 |
| Dec 31, 2025 | 605,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Jun 30, 2025 | 754,000.00 |
| Mar 31, 2025 | 888,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2022 | 630,000.00 |
| Sep 30, 2022 | 466,000.00 |
| Jun 30, 2022 | 228,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 2,000.00 |
API Access
AN2 Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();